Since retiring from the National Hockey League in 2015 at age 30, Daniel Carcillo has dedicated his life to helping athletes and other people like himself who have suffered from traumatic brain injury.
Carcillo was diagnosed with seven concussions in his nine professional seasons and struggled at times with slurred speech, headaches, anxiety, depression, insomnia and other side effects of repeated hits to the head. Two years ago, he implemented a lifestyle change that included an improved diet, more sleep and the use of a psychedelic drug called psilocybin, which he says has made him feel better than ever.
Now, through Wesana Health, a company he co-founded last year, Carcillo is looking to help anyone who has been in his shoes. Wesana Health, which is testing the use of a psychedelic to treat anxiety and depression in people with traumatic brain injury, went public on Monday through the listing of its shares on the Canadian Securities Exchange. And today, the company is announcing a partnership with the World Boxing Council that it hopes will provide a better understanding of traumatic brain injury, a condition that has no U.S. Food and Drug Administration-approved treatments, diagnostics or measurements.
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers